These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33332761)

  • 1. Intravenous arylsulfatase A in metachromatic leukodystrophy: a phase 1/2 study.
    Í Dali C; Groeschel S; Moldovan M; Farah MH; Krägeloh-Mann I; Wasilewski M; Li J; Barton N; Krarup C
    Ann Clin Transl Neurol; 2021 Jan; 8(1):66-80. PubMed ID: 33332761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of intrathecal delivery of recombinant human arylsulfatase A in children with metachromatic leukodystrophy: Results from a phase 1/2 clinical trial.
    Í Dali C; Sevin C; Krägeloh-Mann I; Giugliani R; Sakai N; Wu J; Wasilewski M
    Mol Genet Metab; 2020; 131(1-2):235-244. PubMed ID: 32792226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of intrathecal recombinant arylsulfatase A therapy on structural brain magnetic resonance imaging in children with metachromatic leukodystrophy.
    Groeschel S; Beerepoot S; Amedick LB; Krӓgeloh-Mann I; Li J; Whiteman DAH; Wolf NI; Port JD
    J Inherit Metab Dis; 2024 Jul; 47(4):778-791. PubMed ID: 38321717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of sulfatide on peripheral nerves in metachromatic leukodystrophy.
    Farah MH; Dali CÍ; Groeschel S; Moldovan M; Whiteman DAH; Malanga CJ; Krägeloh-Mann I; Li J; Barton N; Krarup C
    Ann Clin Transl Neurol; 2024 Feb; 11(2):328-341. PubMed ID: 38146590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic Modeling of Intrathecally Administered Recombinant Human Arylsulfatase A (TAK-611) in Children With Metachromatic Leukodystrophy.
    Troy S; Wasilewski M; Beusmans J; Godfrey CJ
    Clin Pharmacol Ther; 2020 Jun; 107(6):1394-1404. PubMed ID: 31868225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracerebroventricular enzyme infusion corrects central nervous system pathology and dysfunction in a mouse model of metachromatic leukodystrophy.
    Stroobants S; Gerlach D; Matthes F; Hartmann D; Fogh J; Gieselmann V; D'Hooge R; Matzner U
    Hum Mol Genet; 2011 Jul; 20(14):2760-9. PubMed ID: 21515587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-inhibitory antibodies impede lysosomal storage reduction during enzyme replacement therapy of a lysosomal storage disease.
    Matzner U; Matthes F; Weigelt C; Andersson C; Eistrup C; Fogh J; Gieselmann V
    J Mol Med (Berl); 2008 Apr; 86(4):433-42. PubMed ID: 18360747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonclinical comparability studies of recombinant human arylsulfatase A addressing manufacturing process changes.
    Wright T; Li A; Lotterhand J; Graham AR; Huang Y; Avila N; Pan J
    PLoS One; 2018; 13(4):e0195186. PubMed ID: 29672630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating meaningful changes in physical functioning and cognitive declines in metachromatic leukodystrophy: a caregiver interview study.
    Martin S; Harris N; Romanus D
    J Patient Rep Outcomes; 2023 Jul; 7(1):70. PubMed ID: 37458805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential of surfactant-coated nanoparticles to improve brain delivery of arylsulfatase A.
    Schuster T; Mühlstein A; Yaghootfam C; Maksimenko O; Shipulo E; Gelperina S; Kreuter J; Gieselmann V; Matzner U
    J Control Release; 2017 May; 253():1-10. PubMed ID: 28215668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of tolerance to human arylsulfatase A in a mouse model of metachromatic leukodystrophy.
    Matzner U; Matthes F; Herbst E; Lüllmann-Rauch R; Callaerts-Vegh Z; D'Hooge R; Weigelt C; Eistrup C; Fogh J; Gieselmann V
    Mol Med; 2007; 13(9-10):471-9. PubMed ID: 17660863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metachromatic leukodystrophy without arylsulfatase A deficiency: a new case of saposin-B deficiency.
    Deconinck N; Messaaoui A; Ziereisen F; Kadhim H; Sznajer Y; Pelc K; Nassogne MC; Vanier MT; Dan B
    Eur J Paediatr Neurol; 2008 Jan; 12(1):46-50. PubMed ID: 17616409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing sulfatide synthesis in myelin-forming cells of arylsulfatase A-deficient mice causes demyelination and neurological symptoms reminiscent of human metachromatic leukodystrophy.
    Ramakrishnan H; Hedayati KK; Lüllmann-Rauch R; Wessig C; Fewou SN; Maier H; Goebel HH; Gieselmann V; Eckhardt M
    J Neurosci; 2007 Aug; 27(35):9482-90. PubMed ID: 17728461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme replacement improves ataxic gait and central nervous system histopathology in a mouse model of metachromatic leukodystrophy.
    Matzner U; Lüllmann-Rauch R; Stroobants S; Andersson C; Weigelt C; Eistrup C; Fogh J; D'Hooge R; Gieselmann V
    Mol Ther; 2009 Apr; 17(4):600-6. PubMed ID: 19174759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme replacement improves nervous system pathology and function in a mouse model for metachromatic leukodystrophy.
    Matzner U; Herbst E; Hedayati KK; Lüllmann-Rauch R; Wessig C; Schröder S; Eistrup C; Möller C; Fogh J; Gieselmann V
    Hum Mol Genet; 2005 May; 14(9):1139-52. PubMed ID: 15772092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial.
    Sessa M; Lorioli L; Fumagalli F; Acquati S; Redaelli D; Baldoli C; Canale S; Lopez ID; Morena F; Calabria A; Fiori R; Silvani P; Rancoita PM; Gabaldo M; Benedicenti F; Antonioli G; Assanelli A; Cicalese MP; Del Carro U; Sora MG; Martino S; Quattrini A; Montini E; Di Serio C; Ciceri F; Roncarolo MG; Aiuti A; Naldini L; Biffi A
    Lancet; 2016 Jul; 388(10043):476-87. PubMed ID: 27289174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo cell-mediated gene therapy for metachromatic leukodystrophy using neurospheres.
    Kawabata K; Migita M; Mochizuki H; Miyake K; Igarashi T; Fukunaga Y; Shimada T
    Brain Res; 2006 Jun; 1094(1):13-23. PubMed ID: 16729983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Juvenile-onset metachromatic leukodystrophy: biochemical and electrophysiologic studies.
    Clark JR; Miller RG; Vidgoff JM
    Neurology; 1979 Mar; 29(3):346-3. PubMed ID: 36575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of five peptide vectors for improved brain delivery of the lysosomal enzyme arylsulfatase A.
    Böckenhoff A; Cramer S; Wölte P; Knieling S; Wohlenberg C; Gieselmann V; Galla HJ; Matzner U
    J Neurosci; 2014 Feb; 34(9):3122-9. PubMed ID: 24573272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Metachromatic leukodystrophy: report of 2 cases with histochemistry of nerves and muscles].
    Werneck LC; Pereira JL; Bruck I
    Arq Neuropsiquiatr; 1980 Sep; 38(3):237-48. PubMed ID: 6110417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.